Search Results - "Dan, Yock‐Young"

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma by Nguyen, Phuong H. D., Ma, Siming, Phua, Cheryl Z. J., Kaya, Neslihan A., Lai, Hannah L. H., Lim, Chun Jye, Lim, Jia Qi, Wasser, Martin, Lai, Liyun, Tam, Wai Leong, Lim, Tony K. H., Wan, Wei Keat, Loh, Tracy, Leow, Wei Qiang, Pang, Yin Huei, Chan, Chung Yip, Lee, Ser Yee, Cheow, Peng Chung, Toh, Han Chong, Ginhoux, Florent, Iyer, Shridhar, Kow, Alfred W. C., Young Dan, Yock, Chung, Alexander, Bonney, Glen K., Goh, Brian K. P., Albani, Salvatore, Chow, Pierce K. H., Zhai, Weiwei, Chew, Valerie

“…The clinical relevance of immune landscape intratumoural heterogeneity (immune-ITH) and its role in tumour evolution remain largely unexplored. Here, we…”
Get full text

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease by Eslam, Mohammed, Sarin, Shiv K., Wong, Vincent Wai-Sun, Fan, Jian-Gao, Kawaguchi, Takumi, Ahn, Sang Hoon, Zheng, Ming-Hua, Shiha, Gamal, Yilmaz, Yusuf, Gani, Rino, Alam, Shahinul, Dan, Yock Young, Kao, Jia-Horng, Hamid, Saeed, Cua, Ian Homer, Chan, Wah-Kheong, Payawal, Diana, Tan, Soek-Siam, Tanwandee, Tawesak, Adams, Leon A., Kumar, Manoj, Omata, Masao, George, Jacob

“…Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The…”
Get full text

Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma by Yong, Kol Jia, Gao, Chong, Lim, Joline S.J, Yan, Benedict, Yang, Henry, Dimitrov, Todor, Kawasaki, Akira, Ong, Chee Wee, Wong, Kwong-Fai, Lee, Sanghoon, Ravikumar, Sharada, Srivastava, Supriya, Tian, Xi, Poon, Ronnie T, Fan, Sheung Tat, Luk, John M, Dan, Yock Young, Salto-Tellez, Manuel, Chai, Li, Tenen, Daniel G

“…SALL4, which is expressed in fetal but not adult liver, is reexpressed in a subgroup of hepatocellular cancers associated with a poor prognosis. In mice,…”
Get full text

Impact of donor age on recipient morbidity and mortality after living donor liver transplantation by Yeow, Marcus, Pang, Ning Qi, Muthiah, Mark D., Soon, Gwyneth, Yock‐Young, Dan, Bonney, Glenn Kunnath, Iyer, Shridhar Ganpathi, Madhavan, Krishnakumar, Kow, Wei Chieh Alfred

“…Background Evidence for use of graft from older donors in living donor liver transplantation (LDLT) has been conflicting. This study aims to clarify the impact…”
Get full text

A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation by Muthiah, Mark D., Huang, Daniel Q., Zhou, Lei, Jumat, Nur Halisah, Choolani, Mahesh, Chan, Jerry Kok Yen, Wee, Aileen, Lim, Seng Gee, Dan, Yock-Young

“…Development of cell transplantation for treating liver cirrhosis hinges critically on the availability of animal models for studying human stem cell…”
Get full text

A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis by Ng, Cheng Han, Tan, Darren Jun Hao, Nistala, Kameswara Rishi Yeshayahu, Syn, Nicholas, Xiao, Jieling, Tan, Eunice Xiang Xuan, Woo, Felicia Zuying, Chew, Nicholas W. S., Huang, Daniel Q., Dan, Yock Young, Sanyal, Arun J., Muthiah, Mark D.

“…Background Current guidelines have limited consensus on the approach to portal venous thrombosis (PVT) in cirrhotic patients. While there is rising interest in…”
Get full text

Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases by Lu, Yonghai, Fang, Jinling, Zou, Li, Cui, Liang, Liang, Xu, Lim, Seng Gee, Dan, Yock-Young, Ong, Choon Nam

“…Introduction Chronic hepatitis B virus (HBV) infection is the main etiologic risk factor for hepatocellular carcinoma (HCC). Early studies indicated that the…”
Get full text

Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients by Muthiah, Mark D., Zheng, Huili, Chew, Nicholas W. S., Xiao, Jieling, Lim, Lee Guan, Tan, Huay-Cheem, Lee, Chi-Hang, Low, Adrian F., Foo, Ling-li, Richards, A. Mark, Dan, Yock-Young, Ho, K. Y., Yip, James W. L., Chan, Mark Y.

“…Omeprazole is commonly co-prescribed with clopidogrel. Clopidogrel requires bio-activation by cytochrome P450 CYP2C19. Omeprazole may reduce clopidogrel’s…”
Get full text

Clinical Service Incorporating Mobile Technology on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Translation From Research Trial by Ang, Siew Min, Lim, Su Lin, Dan, Yock Young, Chan, Yiong Huak, Yap, Qai Ven, Chen, Juliana

“…ABSTRACT Background The prevalence and healthcare cost of metabolic dysfunction–associated steatotic liver disease (MASLD) has increased alongside the epidemic…”
Get full text

Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma by Nguyen, Phuong H. D., Ma, Siming, Phua, Cheryl Z. J., Kaya, Neslihan A., Lai, Hannah L. H., Lim, Chun Jye, Lim, Jia Qi, Wasser, Martin, Lai, Liyun, Tam, Wai Leong, Lim, Tony K. H., Wan, Wei Keat, Loh, Tracy, Leow, Wei Qiang, Pang, Yin Huei, Chan, Chung Yip, Lee, Ser Yee, Cheow, Peng Chung, Toh, Han Chong, Ginhoux, Florent, Iyer, Shridhar, Kow, Alfred W. C., Young Dan, Yock, Chung, Alexander, Bonney, Glen K., Goh, Brian K. P., Albani, Salvatore, Chow, Pierce K. H., Zhai, Weiwei, Chew, Valerie

“…A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-21556-y…”
Get full text

Non-invasive models for predicting histology in patients with chronic hepatitis B by Wai, Chun-Tao, Cheng, Chee Leong, Wee, Aileen, Dan, Yock-Young, Chan, Edwin, Chua, Winnie, Mak, Belinda, Oo, Aung Myat, Lim, Seng Gee

“…: Background and aim: In contrast to chronic hepatitis C (CHC), few studies had been performed in assessing non‐invasive models for predicting significant…”
Get full text

Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice by Teoh, Narci C., Dan, Yock Young, Swisshelm, Karen, Lehman, Stacey, Wright, Jocelyn H., Haque, Jamil, Gu, Yansong, Fausto, Nelson

“…Chromosomal instability is a characteristic feature of hepatocellular carcinoma (HCC) but its origin and role in liver carcinogenesis are undefined. We tested…”
Get full text

Acute-on-chronic liver failure in a multi-ethnic Asian city:A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitions by Selva Rajoo, Anandraj, Lim, Seng-Gee, Phyo, Wah Wah, Tun, Thandar, Dan, Yock-Young, Lee, Yin-Mei, Low, How-Cheng, Lim, Kieron, Tan, Poh-Seng, Lee, Guan-Huei

“…AIM To explore the applicability of the Asia-Pacific Association for the Study of the Liver(APASL) and European Association for the Study of the Liver(EASL)…”
Get full text

A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decade by Lim, Miao‐Shan, Goh, George B‐B, Chang, Jason P‐E, Low, Jee‐Keem, Shelat, Vishalkumar G, Huey, Terence C‐W, Dan, Yock‐Young, Kow, Alfred, Shridhar, Iyer, Tan, Poh‐Seng, Junnarkar, Sameer P, Tan, Chee‐Kiat

“…Background and Aim Hepatocellular carcinoma (HCC) is a significant global problem. With advances in HCC diagnosis and therapy, our hypothesis is that there are…”
Get full text

GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms? by Ong, John, Dan, Yock Young

Get full text

Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk by Lee, Guan-Huei, Tan, Boon-Huan, Chi-Yuan Teo, Esmeralda, Lim, Seng-Gee, Dan, Yock-Young, Wee, Aileen, Kim Aw, Pauline Poh, Zhu, Yuan, Hibberd, Martin Lloyd, Tan, Chee-Kiat, Purdy, Michael A, Teo, Chong-Gee

“…There have been increasing reports of food-borne zoonotic transmission of hepatitis E virus (HEV) genotype 3, which causes chronic infections in…”
Get full text

Prevention of nosocomial SARS-CoV-2 transmission in endoscopy: international recommendations and the need for a gold standard by Ong, John, Cross, Gail B, Dan, Yock Young

Get more information

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis by Tan, Darren Jun Hao, Ng, Cheng Han, Lin, Snow Yunni, Pan, Xin Hui, Tay, Phoebe, Lim, Wen Hui, Teng, Margaret, Syn, Nicholas, Lim, Grace, Yong, Jie Ning, Quek, Jingxuan, Xiao, Jieling, Dan, Yock Young, Siddiqui, Mohammad Shadab, Sanyal, Arun J, Muthiah, Mark D, Loomba, Rohit, Huang, Daniel Q

“…The clinical presentation and outcomes of non-alcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma are unclear when compared with…”
Get full text

What's in a disease like non‐alcoholic fatty liver disease—East versus West? by Dan, Yock Young

“…The Adult Treatment panel III (ATP-III) criteria define metabolic syndrome as a group of conditions that together raise your risk of coronary heart disease,…”
Get full text

Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis by Chan, Wah-Kheong, Treeprasertsuk, Sombat, Goh, George Boon-Bee, Fan, Jian-Gao, Song, Myeong Jun, Charatcharoenwitthaya, Phunchai, Duseja, Ajay, Dan, Yock-Young, Imajo, Kento, Nakajima, Atsushi, Ho, Khek-Yu, Goh, Khean-Lee, Wong, Vincent Wai-Sun

“…Measuring liver stiffness only in patients with indeterminate or high nonalcoholic fatty liver disease (NAFLD) fibrosis scores (called a 2-step approach) was…”
Get full text